(Q33333867)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

review article

1 reference

title

Medical significance of peroxisome proliferator-activated receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

N Latruffe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

English

0 references

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

9173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

141-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Interdomain communication regulating ligand binding by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Differential activation of adipogenesis by multiple PPAR isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Identification of an extended half‐site motif required for the function of peroxisome proliferator‐activated receptor α

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

1 reference

7 January 2021

Mechanisms and clinical effects of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Effect of various n-3/n-6 fatty acid ratio contents of high fat diets on rat liver and heart peroxisomal and mitochondrial beta-oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

The peroxisome proliferator-activated receptor alpha (PPARalpha) ligand WY 14,643 does not interfere with leukotriene B4 induced adhesion of neutrophils to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

1 reference

7 January 2021

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Cross-talk between orphan nuclear hormone receptor RZRalpha and peroxisome proliferator-activated receptor alpha in regulation of the peroxisomal hydratase-dehydrogenase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Peroxisomal lipid metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910364-1

7 January 2021

10.1016/S0140-6736(98)10364-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10408502%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference